Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2008, Vol. 2 Issue (1) : 108-112     DOI: 10.1007/s11684-008-0020-3
The correlated study of hyperuricemia and metabolic syndromes among males of Han ethnicity in the Xinjiang Uygur Autonomous Region, China
YAO Hua1, SUN Yuping2, LI Qing3, YAO Wenhai3, WANG Qiuyun3, HU Jing3, ABUDUREHEMAN Gulibaha3, TUO Ling3, JIANG Yan4
1.Department of Traditional Chinese Medicine, Xinjiang Medical University; 2.Department of Fundamental, Xinjiang Medical University; 3.The Fourth Affiliated Hospital of Xinjiang Medical University; 4.Department of Public Health, Xinjiang Medical University
Download: PDF(82 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  This study investigates the relationship between hyperuricemia and metabolic syndrome (MS) among males of Han ethnicity in the Xinjiang Uygur Autonomous Region, China. The blood samples were collected from January to May, 2006 in Urumqi. It included 1496 subjects with ages between 20 to 70 years. All these subjects had physical examinations, blood pressure (BP) measurement and analysis for serum uric acid (SUA), fasting blood sugar (FBS), serum triglyceride (TG), serum total cholesterol (TC), serum high density lipoprotein (HDL-C) and serum low density lipoprotein (LDL-C) as well as biochemistry assay. The Data were analyzed using the Pearson Chi-Square Test, Independent-Samples T-Test and the Mantel-Haenszel Test for linear trend, respectively. The results show that the prevalence of MS in the present study was 18%. Blood pressure, fasting blood sugar, body mass index (BMI), waist/hip ratio(WHR), TG, TC and LDL-C were significantly higher in the hyperuricemic group than in normal group and these parameters were strongly related to serum uric acid levels. The components of metabolic syndrome such as obesity, hyperglycemia, hypertension and dyslipidemia had a close correlation with SUA. The Odds ratios of these metabolic diseases in the hyperuricemic group were 3.097 times, 2.633 times, 2.226 times and 3.058 times of the normal SUA group, respectively. They all have a positive correlation with hyperuricemia. Hyperuricemia is closely linked to the various components of the metabolic syndrome. More emphasis should be put on the evolving control and prevalence of hyperuricemia and metabolic syndrome among males of Han ethnicity in Xinjiang.
Issue Date: 05 March 2008
URL:     OR
1 Conen D Wietlisbach V Bovet P Shamlaye C Riesen W Paccaud F Burnier M Prevalence of hyperuricemiaand relation of serum uric acid with cardiovascular risk factors ina developing countryBMC Public Health 2004 49
2 Krishnan E Kwoh C K Schumacher H R Kuller L Hyperuricemiaand incidence of hypertension among men without metabolic syndromehypertensionHypertension 2007 49(2)298303
3 Onat A Uyarel H Hergenç G Karabulut A Albayrak S Sari I Yazici M Keleş I Serum uric acid is a determinantof metabolic syndrome in a population-based studyAm J Hypertens 2006 19(10)10551062
4 Yoo T W Sung K C Shin H S Kim B J Kim B S Kang J H Lee M H Park J R Kim H Rhee E J Lee W Y Kim S W Ryu S H Keum D G Relationshipbetween serum uric acid concentration and insulin resistance and metabolicsyndromeCirc J 2005 69(8)928933
5 Expert Panel on Detection, Evaluation, and Treatmentof High Blood Cholesterol in Adults. Executive Summary of the ThirdReport of the National Cholesterol Education Program (NCEP) ExpertPanel on Detection, Evaluation, and Treatment of High Blood Cholesterolin Adults (Adult Treatment Panel III)JAMA 2001 28524862497
6 The Chinese Diabetes Society of Chinese MedicalAssociation Group. The subject in metabolic syndrome of Chinese DiabetesSociety of Chinese Medical Association Group definitionZhongguo Tangniaobing Zazhi 2004 12(3)156161 (in Chinese)
7 Shankar A Klein R Klein B E Nieto F J The associationbetween serum uric acid level and long-term incidence of hypertension:Population-based cohort studyJ Hum Hypertens 2006 20(12)937945
8 Niskanen L K Laaksonen D E Nyyssönen K Alfthan G Lakka H M Lakka T A Salonen J T Uric acid level as a risk factorfor cardiovascular and all cause mortality in middle aged men: a prospectivecohort studyArch Intern Med 2004 164(14)154155
9 Heinig M Johnson R J Role of uric acid in hypertension,renal disease, and metabolic syndromeCleveClin J Med 2006 73(12)10591064
10 Quinones Galvan A Natali A Baldi S Frascerra S Sanna G Ciociaro D Ferrannini E Effectof insulin on uric acid excretion in humansAm J Physiol 1995 268
11 Vuorinen-Markkola H Yki-Jarvinen H Hyperuricemia and insulin resistance.J Clin Endo Metab. 1994 78(1)2529
12 Facchini F Chen Y D Hollenbeck C B Reaven G M Relationshipbetween resistance to insulin-mediated glucose uptake, urinary uricacid clearance, and plasma uric acid concentrationJAMA 1991 266(21)30083011
13 Lohsoonthorn V Dhanamun B Williams M A Prevalence of hyperuricemia and its relationship with metabolicsyndrome in thai adults receiving annual health exams. Arch Med Res. 2006 37(7)883889
14 Kawamoto R Tomita H Oka Y Ohtsuka N Relationshipbetween serum acid concentration, metablitic syndrome and carotidatherosclerosis. Intern Med. 2006 45(9)605614
15 Wang L Q Zuo W J Cai S N The clinical analysis on 129 cases hyperuricemiaZhongguo Yejin Gongye Yixue Zazhi 2004 21(6)504 (in Chinese)
16 Zhao L C Wu Y F Li Y Zhou B F Yang J Relation of body mass index and waist circumferencewith clustering of other risk factors for cardiovascular diseaseZhonghua Yufang Yixue Zazhi 2003 37(5)346350 (in Chinese)
17 Bonora E Targher G Zenere M B Saggiani F Cacciatori V Tosi F Travia D Zenti M G Branzi P Santi L Muggeo M Relationshipof uric acid concentration to cardiovascular risk factors in youngmen. Role of obesity and central fat distribution. The Verona YoungMen Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996 20(11)975980
18 Hamada N visceralobesity and hyperuricemiaRiben Yixue Jieshao 2006 27(2)7577 (in Chinese)
19 Nieto F J Iribarren C Gross M D Comstock G W Cutler R G Uric acid and serum antioxidant capacity:a reaction to atherosclerosis?Atherosclerosis 2000 148(1)131139
20 Leyva F Wingrove C S Godsland I F Stevenson J C Theglycolytic pathway to coronary heart disease: a hypothesisMetabolism 1998 47(6)657662Review
No related articles found!
Full text